Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2015
|
| gptkbp:ATCCode |
V03AE10
|
| gptkbp:chemicalFormula |
(C6H7KO4)n
|
| gptkbp:contraindication |
severe gastrointestinal disorders
|
| gptkbp:form |
oral powder for suspension
|
| gptkbp:genericName |
gptkb:patiromer
|
| https://www.w3.org/2000/01/rdf-schema#label |
Veltassa
|
| gptkbp:indication |
hyperkalemia
|
| gptkbp:legalStatus |
Rx-only (US)
|
| gptkbp:manufacturer |
gptkb:Vifor_Pharma
|
| gptkbp:mechanismOfAction |
potassium binder
|
| gptkbp:pregnancyCategory |
Not assigned (consult physician)
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
diarrhea constipation hypomagnesemia |
| gptkbp:website |
https://www.veltassa.com/
|
| gptkbp:bfsParent |
gptkb:patiromer
|
| gptkbp:bfsLayer |
8
|